ArticleIntensive care medicine2017
Super-refractory status epilepticus: epidemiology, early predictors, and outcomes.
Article in Intensive care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Assessment of therapeutic management practices in generalized and focal motor status epilepticus: An international survey in French, Belgian, and Swiss intensive care units.Journal of intensive medicine · 2026Article
- Status epilepticus in the ICU.Intensive care medicine · 2024Review
- Outcomes and Treatment Approaches for Super-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis.JAMA neurology · 2023Article
- Factors associated with mortality in patients with super-refractory status epilepticus.Scientific reports · 2022Article
- [Management of refractory and super-refractory status epilepticus].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2019Review
- Status epilepticus: Role for etiology in determining response to benzodiazepines.Annals of neurology · 2018Article
- Successful use of pure cannabidiol for the treatment of super-refractory status epilepticus.Epilepsy & behavior case reports · 2018Article
- Multimodal Predictions of Super-Refractory Status Epilepticus and Outcome in Status Epilepticus Due to Acute Encephalitis.Frontiers in neurology · 2018Article
- Updates in Refractory Status Epilepticus.Critical care research and practice · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28497271What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.